FDA Adverse Event Injury Summary report: N

DERMABOND ADVANCED

MDR report key: 2821863 · Received November 6, 2012

Report

Report Number
2210968-2012-07083
Event Type
Injury
Date Received
November 6, 2012
Date of Event
August 18, 2012
Report Date
October 11, 2012
Manufacturer
ETHICON, INC.
Product Code
MPN
PMA / PMN Number
P960052
Removal / Correction Number
NA
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
JA
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

(B)(4) - PROBLEM WITH PIGMENTATION. ADDITIONAL NARRATIVE: IT WAS REPORTED THAT THE THREE PORT AREAS OF THE CHEST IS WHERE IS REACTION OCCURRED. THE SYMPTOMS WERE REDNESS AND RASH. AS OF (B)(6) 2012, THE REDNESS, RASH AND ITCHING WERE GONE, BUT THERE WAS PIGMENTATION. THE PATIENT IS DOING WELL.

Additional Manufacturer Narrative · 1

(B)(4). CONCLUSION: NO CONCLUSION CAN BE DRAWN AT THIS TIME. SHOULD ADDITIONAL INFORMATION BE OBTAINED, A SUPPLEMENTAL 3500A FORM WILL BE SUBMITTED ACCORDINGLY. ADDITIONAL INFORMATION: THE ACTUAL DEVICE BATCH NUMBER ASSOCIATED WITH THIS EVENT IS NOT KNOWN. THE INTERNATIONAL AFFILIATE REPORTS THE FOLLOWING POSSIBLE BATCH NUMBER: EAE182. IN ADDITION, A REVIEW OF THE BATCH MANUFACTURING RECORDS FOR THE POSSIBLE BATCH NUMBER WAS CONDUCTED AND THE BATCH MET ALL FINISHED GOODS RELEASE CRITERIA.

Description of Event or Problem · 1

IT WAS REPORTED THAT A PATIENT UNDERWENT A THYMIC TUMOR RESECTION ON (B)(6) 2012 AND A TOPICAL SKIN ADHESIVE WAS USED AT THE PORT AREAS. ON (B)(6) 2012 THE PATIENT DEVELOPED REDNESS AND ITCHING AT THE SITE OF APPLICATION. ON (B)(6) 2012, THE TOPICAL ADHESIVE WAS REMOVED AND THE PATIENT WAS TREATED WITH ALLEGRA AND ANTEBATE. THE PATIENT'S SYMPTOMS RESOLVED. ON (B)(6) 2012 COMPLAINED OF ITCHING AGAIN. THE DOCTOR PRESCRIBED ALLEGRA AND ANTEBATE AGAIN. UNSPECIFIED ORAL MEDICINE WAS ALSO PRESCRIBED. NOW, THE PATIENT IS IN STABLE CONDITION.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 DERMABOND ADVANCED TOPICAL SKIN ADHESIVE MPN ETHICON, INC. NA NI

Patients

Seq Age Sex Outcome Treatment
1 64 YR Required Intervention